PhotoCure ASA (PhotoCure ASA) Asset Impairment Charge : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Asset Impairment Charge?

PhotoCure ASA's Asset Impairment Charge for the three months ended in Mar. 2024 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

PhotoCure ASA Asset Impairment Charge Historical Data

The historical data trend for PhotoCure ASA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Asset Impairment Charge Chart

PhotoCure ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

PhotoCure ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

PhotoCure ASA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

PhotoCure ASA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA (PhotoCure ASA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

PHOO:Sweden PHO:Norway 0IMT:UK

Address

Hoffsveien 4, Oslo, NOR, 0275

Website

https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.